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Abstract Using a non-radioactive iodine-127 labeled cerebral perfusion agent (1-127 IMP), fluorescent X-ray computed
tomography (FXCT) clearly revealed the cross-sectional distribution of 1-127 IMP in normal mouse brain in-vivo.
Cerebral perfusion of cortex and basal ganglion was depicted with 1 mm in-plane spatialresolution and 0.1 mm slice
thickness.Degree of cerebral perfusion in basal ganglion was about 2-fold higher than thatin corticalregions. This result
suggests thatin-vivo cerebral perfusion imaging is realized quantitativelyby FXCT at high volumetric resolution.
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INTRODUCTION
In biomedical field,functional evaluation is quite useful to understand the process, diagnosis and treatment of
various diseases [1]. Micro positron emission tomography (micro-PET) [1-3] and micro single photon emission
computed tomography (micro-SPECT) [4, 5] are recently used to visualizein-vivo biochemical processes in small
animal. However, the use of radionuclide agent is indispensable in PET and SPECT study, and the volumetric
resolutionof these techniques islimited to about 1 mm3 and 0.5 -0.1 mm3, respectively.
Fluorescent X-ray technique using synchrotron X-ray, which is usually used to observe the surface of the object,
can detect very low contents of medium or heavy trace elements with concentrationsin the order of picograms [6],
To depict the distributionof specific elements inside the object without slicing procedure, fluorescent X-ray
computed tomography (FXCT) with synchrotron radiationis being developed [7-10]. The FXCT could depictiodine
within a phantom, and the endogenous iodine of an excised human thyroid [11-13]. Furthermore, the FXCT was
applied to assess the functionalinformation of ex-vivo brain and heart of small animals similar to autoradiogram,
and we successfully observed the cerebral blood flow [14] and myocardial fatty acid metabolism [15, 16] after
injecting various types of non-radioactiveiodine labeled agent. Since the significantresults were obtained by ex-
vivo studies,in-vivo FXCT imaging was performed by using a germanium detector with high count rate capability
and energy resolution [17]. Here, the experimental results of in-vivo cerebralblood flow imaging of mouse brain
obtained by FXCT is described.
METHODS AND MATERIALS
The experiment was carriedout at the bending-magnet beam line BLNE-5 A of the Tristan accumulation ring(6.5
GeV) in Tsukuba, Japan. The photon flux ratein front of the object was approximately 9.3 x 107 photons/mm2/s for
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FIGURE 1. Schematic diagram of fluorescent X-ray computed tomography system.
beam current of 40 mA. FXCT system consists of a silicon(220) double crystal monochromator, an X-ray slit
system, a scanning table for subject positioning, a fluorescent X-ray detector, and two pin-diode detectors for
incident X-ray and transmission X-ray data (Fig. 1).The white X-ray beam was monochromatized to 37 keV X-ray
energy. The monochromatic X-ray was coUimated into a pencil beam (1 x 0.1 or 0.2 mm2: horizontal and vertical
direction).Fluorescent X-rays induced by incident X-ray beam were detected in a high purity germanium (HPGe)
detector operating in the photon-counting mode, and the HPGe detector was oriented perpendicular to the incident
monochromatic X-ray beam. The data acquisitiontime of the HPGe detectorfor each scanning step was set 5-s.
Objects were 3 mice and an acrylicphantom with three sub-holes. Since radioactive1-123 labeled N-isopropyl-p-
iodoamphetamine (1-123 IMP) is popularly used to evaluate cerebral blood flow in clinicalSPECT study [18], we
attempted to use a non-radioactive 1-127 labeled IMP (1-127 IMP) for in-vivo FXCT imaging of mouse. In-vivo
FXCT imaging of mouse started 5 min after intravenous injection of 1-127 IMP under the anesthetized with
pentobarbital.The 20-mm in diameter acrylicphantom filledwith various concentration of iodine solution was also
imaged to determine the absoluteiodine content within brain. Object was scanned with 1-mm translationstep over
target range and 6 degree rotation step over a range of 180 degrees. FXCT images were reconstructed by the
algebraic method with attenuation correction for the incident beam and the emitted fluorescent X-ray using the
TXCT data [19]. The TXCT image was reconstructed by using the filteredback projection method with the Shepp
and Logan filter.
Our present experiment was approved by the Medical Committee for the Use of Animals in Research of the
University of Tsukuba, and it conformed to the guidelines of the American Physiological Society.
1945
5i
250
200
150
100
50
0
0 100 200 300
Position
400
FIGURE 2. Cerebral perfusion image with 1-127 IMP and itsprofileanalysis of a mouse brain by fluorescent X-ray
computed tomography.
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RESULTS AND DISCUSSIONS
In-vivo cerebral perfusion of mouse was clearly imaged by FXCT at an 1 mm spatial resolution with a 0.1 or 0.2
mm slice thickness (Fig. 2). Cerebral cortex and basal ganglion were well visualized, and the cerebral perfusion in
basal ganglion was about 2-fold higher than other cortical regions probably due to anesthesia. Reduced cerebral
perfusion in left cerebral cortex might be caused by ischemia. In profile analysis, the degree of regional cerebral
perfusion was assessed quantitatively as shown in Fig. 2. Using calibration data from the phantom, cerebral uptake
of the iodine in mouse was estimated about 0.02-0.04 mg/g.
The volumetric resolution of this in-vivo FXCT image was 0.1 or 0.2 mm3 (1-mm x 1-mm x 0.1 or 0.2-mm).
This resolution was almost comparable to super micro-SPECT imaging as 0,1 mm3 [5, 20]. Since the duration of
anesthesia is limited, in this study, the spatial resolution had been restricted to 1 mm by scanning time. However, we
can obtain much higher spatial resolution image of 0.5-mm with a 0.4-mm slice thickness by using the HPGe
detector with much higher count rate capability. For this purpose, we are now developing high speed FXCT system.
In addition, the use of non-radioactive agent is significantly suitable to perform the biomedical experiment because
the preparation of drug and experiment are quite easy without radiation exposure for researchers.
Thus, in-vivo FXCT is a powerful tool to image the functional information with high spatial resolution and
without the use of non radioactive labeling agents.
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